Axcella Health Inc. (AXLA)
| Previous close | 4.5800 |
| Open | 0.3600 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 1100 |
| Day's range | 4.5800 - 4.5800 |
| 52-week range | 4.5800 - 4.5800 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider Monkey12 Best Stocks For Day Trading
In this piece, we will take a look at the 12 Best Stocks For Day Trading. If you want to skip our introduction to trading indicators and the economic climate, then check out 5 Best Stocks For Day Trading. The modern day stock market is significantly different from the one of the early 1900s. These […]
ZacksAre Medical Stocks Lagging Axcella Health (AXLA) This Year?
Here is how Axcella Health Inc. (AXLA) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.
Business WireAxcella Announces Reverse Stock Split Effective September 19, 2023
CAMBRIDGE, Mass., September 14, 2023--Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic modulators (EMMs), today announced that its Board of Directors has approved a 1-for-25 reverse stock split of the Company’s common stock. The reverse stock split will become effective at 5:00 p.m. Eastern Time on September 18, 2023, after close of trading on The
